An AI-Based CDSS for Integrated Management of Patients With Acute Ischemic Stroke(GOLDEN BRIDGE II)
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 21689 participants.
Also called NCT04524624
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 21,689 participants
- Sponsor
- Registry
-
NCT04524624
-
- Other papers using this trial's data
- Effect of a clinical decision support system on stroke care quality and outcomes in patients with acute ischaemic stroke (GOLDEN BRIDGE II): cluster randomised clinical trial
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04524624. Randomized; single masking; primary purpose prevention. Start 2020-09-01 (anticipated); primary completion 2022-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- An AI-Based CDSS for Integrated Management of Patients With Acute Ischemic Stroke(GOLDEN BRIDGE II)
- Condition
- Stroke
- Intervention (Device)
- AI-based CDSS
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct04524624- Content hash
d5ff63fe359dc60aeab41de863e58f23b2bc44c189e3fe15a56fcb5719674546